Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio's Approved Drugs Database

Targretin

Bexarotene

Download PDF containing detailed information. PDF Version

Image Results

Press Releases About Targretin:
Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma	15th July, 2008	Cephalon, Inc.	FRAZER, Pa., July 15 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) announced today that in a phase 2 study published online today in the Journal of Clinical Oncology, 92 percent of

Companies working in the area of Targretin from Bioportfolio's Biocorporate database :
Company Name
Ligand Pharmaceuticals Ligand is an emerging specialty pharmaceutical company that discovers, develops and markets innovative small molecule drugs to address critical, unmet medical needs. Ligand markets four oncology and... www.ligand.com/ View full profile

This page has been viewed 24 times
Recent Search Terms used to find this page: .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Targretin across BioPortfolio, or for Targretin Research Reports

Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

BioPortfolio's Approved Drugs Database

Targretin

Bexarotene

Image Results

Press Releases About Targretin:

Companies working in the area of Targretin from Bioportfolio's Biocorporate database :

Ligand Pharmaceuticals